0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Semaphorin 4D

Semaphorin 4D

Brief Information

Name:Semaphorin 4D
Target Synonym:SEMAJ,SEMA4D,Semaphorin 4D,Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Short Cytoplasmic Domain, (Semaphorin) 4D,C9orf164,CD100,BB18,GR3,A8,Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Short Cytoplasmic
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CD0-H5257 Human Human Semaphorin 4D / SEMA4D / CD100 Protein, Fc Tag
CD0-H5257-structure
CD0-H5257-sds

Synonym Name

SEMA4D,C9orf164,CD100,FLJ33485,FLJ34282,FLJ39737,FLJ46484,M-sema-G,MGC169138,MGC169141,SEMAJ,coll-4,Semaphorin-4D

Background

Cluster of Differentiation 100 (CD100) is also known as Semaphorin-4D (SEMA4D), is a single-pass type I membrane protein which belongs to the

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Pepinemab VX-15; VX-15/2503; moAb VX-15/2503 Phase 2 Clinical Vaccinex Solid tumours; Squamous Cell Carcinoma of Head and Neck; Multiple Sclerosis; Huntington Disease; Alzheimer Disease; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop